
PubMed:2205477
Annnotations
jnlpba-st-training
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 4-32 | protein | denotes | glucocorticoid binding sites |
T2 | 40-69 | protein | denotes | human glucocorticoid receptor |
T3 | 123-137 | cell_type | denotes | leukemic cells |
T4 | 164-187 | protein | denotes | glucocorticoid receptor |
T5 | 189-191 | protein | denotes | GR |
T6 | 253-255 | protein | denotes | GR |
T7 | 493-505 | cell_line | denotes | CEM C7 cells |
T8 | 509-546 | cell_line | denotes | human acute lymphoblastic T-cell line |
T9 | 831-845 | cell_type | denotes | leukemic cells |
T10 | 996-1008 | cell_line | denotes | CEM C7 cells |
T11 | 1070-1102 | protein | denotes | higher affinity CVZ binding site |
T12 | 1186-1197 | cell_line | denotes | B-cell line |
T13 | 1199-1203 | cell_line | denotes | IM-9 |
T14 | 1311-1330 | protein | denotes | CVZ's binding sites |
T15 | 1397-1399 | protein | denotes | GR |
T16 | 1540-1568 | protein | denotes | glucocorticoid binding sites |
T17 | 1582-1584 | protein | denotes | GR |
pubmed-sentences-benchmark
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
S1 | 0-70 | Sentence | denotes | Two glucocorticoid binding sites on the human glucocorticoid receptor. |
S2 | 71-193 | Sentence | denotes | Glucocorticoids are known to have a lytic effect in leukemic cells via interactions with the glucocorticoid receptor (GR). |
S3 | 194-279 | Sentence | denotes | Cortisol and various synthetic glucocorticoids bind to the GR with one-site kinetics. |
S4 | 280-548 | Sentence | denotes | Cortivazol (CVZ) is a unique, high potency synthetic glucocorticoid, which has a phenylpyrazol fused to the A-ring of the steroid nucleus and displays binding consistent with two or more sites in the cytosol from CEM C7 cells (a human acute lymphoblastic T-cell line). |
S5 | 549-696 | Sentence | denotes | It has previously been shown that the lower affinity class of sites are similar in affinity and site molarity to those recognized by dexamethasone. |
S6 | 697-820 | Sentence | denotes | The higher affinity sites bind CVZ with 20- to 50-fold greater affinity, consistent with CVZ's enhanced biological effects. |
S7 | 821-1009 | Sentence | denotes | In mutant leukemic cells resistant to the lytic effects of dexamethasone, CVZ both lyses the cells and recognizes a single class of sites similar to the high affinity site in CEM C7 cells. |
S8 | 1010-1103 | Sentence | denotes | We have carried out experiments to define the nature of the higher affinity CVZ binding site. |
S9 | 1104-1491 | Sentence | denotes | We now show that: 1) CVZ has more than one binding site in a second, independent, B-cell line, IM-9; 2) the antiglucocorticoid RU 38486 is able to block both CVZ's higher and lower affinity sites; 3) all of CVZ's binding sites are on a protein immunologically indistinguishable from the human GR; and 4) freshly isolated clones of CVZ-resistant cells have lost all binding sites for CVZ. |
S10 | 1492-1617 | Sentence | denotes | These data indicate that CVZ is recognizing two glucocorticoid binding sites on the human GR or a protein very similar to it. |
genia-medco-coref
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
C1 | 0-32 | NP | denotes | Two glucocorticoid binding sites |
C2 | 36-69 | NP | denotes | the human glucocorticoid receptor |
C3 | 160-192 | NP | denotes | the glucocorticoid receptor (GR) |
C4 | 249-255 | NP | denotes | the GR |
C5 | 280-296 | NP | denotes | Cortivazol (CVZ) |
C6 | 300-347 | NP | denotes | a unique, high potency synthetic glucocorticoid |
C7 | 349-354 | NP | denotes | which |
C8 | 493-547 | NP | denotes | CEM C7 cells (a human acute lymphoblastic T-cell line) |
C9 | 602-616 | NP | denotes | class of sites |
C10 | 662-667 | NP | denotes | those |
C11 | 682-695 | NP | denotes | dexamethasone |
C12 | 697-722 | NP | denotes | The higher affinity sites |
C13 | 728-731 | NP | denotes | CVZ |
C14 | 786-789 | NP | denotes | CVZ |
C16 | 880-893 | NP | denotes | dexamethasone |
C15 | 824-893 | NP | denotes | mutant leukemic cells resistant to the lytic effects of dexamethasone |
C17 | 895-898 | NP | denotes | CVZ |
C18 | 910-919 | NP | denotes | the cells |
C19 | 996-1008 | NP | denotes | CEM C7 cells |
C20 | 1066-1102 | NP | denotes | the higher affinity CVZ binding site |
C21 | 1125-1128 | NP | denotes | CVZ |
C22 | 1163-1197 | NP | denotes | a second, independent, B-cell line |
C23 | 1199-1203 | NP | denotes | IM-9 |
C24 | 1262-1265 | NP | denotes | CVZ |
C26 | 1311-1314 | NP | denotes | CVZ |
C25 | 1304-1330 | NP | denotes | all of CVZ's binding sites |
C28 | 1487-1490 | NP | denotes | CVZ |
C27 | 1465-1490 | NP | denotes | all binding sites for CVZ |
C29 | 1517-1520 | NP | denotes | CVZ |
C30 | 1536-1568 | NP | denotes | two glucocorticoid binding sites |
C31 | 1572-1584 | NP | denotes | the human GR |
R1 | C4 | C3 | coref-ident | the GR,the glucocorticoid receptor (GR) |
R2 | C7 | C6 | coref-relat | which,"a unique, high potency synthetic glucocorticoid" |
R3 | C10 | C9 | coref-pron | those,class of sites |
R4 | C13 | C5 | coref-ident | CVZ,Cortivazol (CVZ) |
R5 | C14 | C13 | coref-ident | CVZ,CVZ |
R6 | C16 | C11 | coref-ident | dexamethasone,dexamethasone |
R7 | C17 | C14 | coref-ident | CVZ,CVZ |
R8 | C18 | C15 | coref-ident | the cells,mutant leukemic cells resistant to the lytic effects of dexamethasone |
R9 | C19 | C8 | coref-ident | CEM C7 cells,CEM C7 cells (a human acute lymphoblastic T-cell line) |
R10 | C20 | C12 | coref-ident | the higher affinity CVZ binding site,The higher affinity sites |
R11 | C21 | C17 | coref-ident | CVZ,CVZ |
R12 | C23 | C22 | coref-appos | IM-9,"a second, independent, B-cell line" |
R13 | C24 | C21 | coref-ident | CVZ,CVZ |
R14 | C26 | C24 | coref-ident | CVZ,CVZ |
R15 | C28 | C26 | coref-ident | CVZ,CVZ |
R16 | C27 | C25 | coref-ident | all binding sites for CVZ,all of CVZ's binding sites |
R17 | C29 | C28 | coref-ident | CVZ,CVZ |
R18 | C30 | C1 | coref-ident | two glucocorticoid binding sites,Two glucocorticoid binding sites |
R19 | C31 | C2 | coref-ident | the human GR,the human glucocorticoid receptor |
GENIAcorpus
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 4-32 | protein_domain_or_region | denotes | glucocorticoid binding sites |
T2 | 40-69 | protein_family_or_group | denotes | human glucocorticoid receptor |
T3 | 71-86 | lipid | denotes | Glucocorticoids |
T4 | 123-137 | cell_type | denotes | leukemic cells |
T5 | 164-187 | protein_family_or_group | denotes | glucocorticoid receptor |
T6 | 189-191 | protein_family_or_group | denotes | GR |
T7 | 194-202 | lipid | denotes | Cortisol |
T8 | 215-240 | lipid | denotes | synthetic glucocorticoids |
T9 | 253-255 | protein_family_or_group | denotes | GR |
T10 | 261-278 | other_name | denotes | one-site kinetics |
T11 | 280-290 | other_organic_compound | denotes | Cortivazol |
T12 | 292-295 | other_organic_compound | denotes | CVZ |
T13 | 323-347 | other_organic_compound | denotes | synthetic glucocorticoid |
T14 | 361-374 | other_organic_compound | denotes | phenylpyrazol |
T15 | 388-394 | other_organic_compound | denotes | A-ring |
T16 | 402-417 | lipid | denotes | steroid nucleus |
T17 | 493-505 | cell_line | denotes | CEM C7 cells |
T18 | 509-546 | cell_line | denotes | human acute lymphoblastic T-cell line |
T19 | 632-640 | other_name | denotes | affinity |
T20 | 645-658 | other_name | denotes | site molarity |
T21 | 682-695 | lipid | denotes | dexamethasone |
T22 | 701-707 | other_name | denotes | higher |
T23 | 708-716 | other_name | denotes | affinity |
T24 | 728-731 | other_organic_compound | denotes | CVZ |
T25 | 760-768 | other_name | denotes | affinity |
T26 | 786-789 | other_organic_compound | denotes | CVZ |
T27 | 801-819 | other_name | denotes | biological effects |
T28 | 831-845 | cell_type | denotes | leukemic cells |
T29 | 880-893 | lipid | denotes | dexamethasone |
T30 | 895-898 | other_organic_compound | denotes | CVZ |
T31 | 979-987 | other_name | denotes | affinity |
T32 | 996-1008 | cell_line | denotes | CEM C7 cells |
T33 | 1070-1076 | protein_domain_or_region | denotes | higher |
T34 | 1077-1085 | other_name | denotes | affinity |
T35 | 1086-1089 | other_organic_compound | denotes | CVZ |
T36 | 1125-1128 | other_organic_compound | denotes | CVZ |
T37 | 1186-1197 | cell_line | denotes | B-cell line |
T38 | 1199-1203 | cell_line | denotes | IM-9 |
T39 | 1212-1230 | other_name | denotes | antiglucocorticoid |
T40 | 1231-1239 | other_organic_compound | denotes | RU 38486 |
T41 | 1262-1265 | other_organic_compound | denotes | CVZ |
T42 | 1285-1293 | other_name | denotes | affinity |
T43 | 1311-1314 | other_organic_compound | denotes | CVZ |
T44 | 1397-1399 | protein_family_or_group | denotes | GR |
T45 | 1435-1438 | other_organic_compound | denotes | CVZ |
T46 | 1487-1490 | other_organic_compound | denotes | CVZ |
T47 | 1517-1520 | other_organic_compound | denotes | CVZ |
T48 | 1540-1568 | protein_domain_or_region | denotes | glucocorticoid binding sites |
T49 | 1582-1584 | protein_family_or_group | denotes | GR |